Source comparison
Comparison: MOTS-c vs. AICAR in Glucose Metabolism Research
AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) is a well-established pharmacological AMPK activator commonly used as a comparator in AMPK pathway research. Comparing MOTS-c to AICAR in glucose metabolism experiments helps contextualize the magnitude and
This comparison does not assign a generated winner or score.
- AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) is a well-established pharmacological AMPK activator commonly used as a comparator in AMPK pathway research. Comparing MOTS-c to AICAR in glucose metabolism experiments helps contextualize the magnitude and mechanism of MOTS-c's effects.
- Similarities:
- Both activate AMPK and promote GLUT4 translocation
- Both improve glucose uptake in skeletal muscle cell models
- Both have been shown to reduce insulin resistance markers in HFD rodent models
- Differences:
- MOTS-c is endogenously produced by mitochondria; AICAR is a synthetic compound not found naturally in cells
- MOTS-c has broader signaling reach including nuclear translocation; AICAR's effects are more limited to AMPK pathway activation
- The upstream mechanisms of AMPK activation differ between the two compounds
- This comparison is useful for researchers designing experiments that need a positive control for AMPK-mediated glucose effects.